Both in Pharmaceuticals
Septerna vs Aurinia Pharmaceuticals
Over the past year SEPN returned +146.0% and AUPH returned +19.9%; their daily moves had a correlation of 0.23.
SEPN +146.0% AUPH +19.9%Growth of $1, one year, split-adjusted
| Metric | SEPN | AUPH |
|---|---|---|
| Price | $47.88 | $17.11 |
| Market cap | $2.23B | $2.29B |
| Today | +9.57% | +3.32% |
| 1 month | +34.2% | +9.1% |
| 6 months | +93.8% | +5.3% |
| Year to date | +71.7% | +7.3% |
| 1 year | +138.8% | +29.9% |
| Revenue growth (YoY) | +22375.6% | +13.9% |
| Gross margin | 100.0% | 90.1% |
| Net margin | −48.7% | 37.9% |
| P/E (TTM) | — | 7.3× |
| Price / sales | 22.6× | 7.1× |
| Net cash | $372.3M | $431.7M |
| Dividend yield | — | — |
| Volatility (60d) | 49.1% | 31.0% |
| Short % of float | 12.0% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).